|
1
|
Macciò A, Madeddu C, Gramignano G, Mulas
C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A and Ganz T:
The role of inflammation, iron, and nutritional status in
cancer-related anemia: Results of a large, prospective,
observational study. Haematologica. 100:124–132. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Steegman JL, Sánchez Torres JM, Colomer R,
Vaz Á, López J, Jalón I, Provencio M, González-Martín A and Pérez
M: Prevalence and management of anaemia in patients with
non-myeloid cancer undergoing systemic therapy: A Spanish survey.
Clin Transl Oncol. 15:477–483. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Knight K, Wade S and Balducci L:
Prevalence and outcomes of anemia in cancer: A systematic review of
literature. Am J Med. 116 (Suppl 7A):11S–26S. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schrijvers D, De Samblanx H and Roila F:
ESMO Guidelines Working Group: Erythropoiesis-stimulating agents in
the treatment of anemia in cancer patients: ESMO clinical practice
guidelines for use. Ann Oncol. 21:v244–v247. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schwartz RN: Anemia in patients with
cancer: Incidence, causes, impact, management, and use of treatment
guidelines and protocols. Am J Health Syst Pharm. 64 (Suppl
2):S5–S13. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
National Cancer Institute National
Institutes of Health, U.S. Department of Health and Human Services.
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0;
NIH publication #09-7473. Published May 28, 2009; Revised Version
4.03 Jun 14, 2010.
|
|
7
|
Henry D and Dahl N: Iron or vitamin B12
deficiency in anemic cancer patients prior to erythropoiesis
stimulating agent therapy. Community Oncol. 4:351–356. 2007.
View Article : Google Scholar
|
|
8
|
Rodgers GM III, Becker PS, Blinder M,
Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B,
Gilreath JA, Kraut EH, et al: Cancer- and chemotherapy-induced
anemia. J Natl Compr Canc Netw. 10:628–653. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Spivak JL, Gascon P and Ludwig H: Anemia
management in oncology and hematology. Oncologist. 14:43–56.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Antonuzzo A, Lucchesi M, Brunetti IM,
Galli L, Vasile E, Bonci F, Ricci S and Falcone A: Supportive care
and not only palliative care in the route of cancer patients.
Support Care Cancer. 21:657–658. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Harper P and Littlewood T: Anaemia of
cancer: Impact on patient fatigue and long term outcome. Oncology.
69:2–7. 2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ryan JL, Carroll JK, Ryan EP, Mustian KM,
Fiscella K and Morrow GR: Mechanisms of cancer-related fatigue.
Oncologist. 12:22–34. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Caro JJ, Salas M, Ward A and Goss G:
Anemia as an independent prognostic factor for survival in patients
with cancer: A systematic, quantitative review. Cancer.
91:2214–2221. 2001.PubMed/NCBI
|
|
14
|
Ripamonti CI, Molani P, Desti C, Boscagli
G, Ravagnani F, Arienti F and Di Cristo C: A supportive care in
cancer unit reduces costs and hospitalizations for transfusions in
a comprehensive cancer center. Tumori. 18:449–456. 2017.PubMed/NCBI View Article : Google Scholar
|
